Lysins as a powerful alternative to combat Bacillus anthracis
Applied Microbiology and Biotechnology · 2024
DOI: 10.1007/s00253-024-13194-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Applied Microbiology and Biotechnology, 2024. Verfasst von Aleksandra Nakonieczna und 3 weiteren Autor:innen. Beteiligte Einrichtung: Military Institute of Hygiene and Epidemiology, Biological Threats Identification and Countermeasure Center, Puławy, 24-100, Poland. aleksandra.nakon…. Hauptthemen laut MEDLINE: Bacillus anthracis, Anthrax, Endopeptidases, Anti-Bacterial Agents. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This review gathers all, to the best of our current knowledge, known lysins, mainly bacteriophage-derived, that have demonstrated activity against Bacillus anthracis strains. B. anthracis is a spore-forming, toxin-producing bacteria, naturally dwelling in soil. It is best known as a potential biowarfare threat, an etiological agent of anthrax, and a severe zoonotic disease. Anthrax can be treated with antibiotics (ciprofloxacin, penicillin, doxycycline); however, their administration may take up even to 60 days, and different factors can compromise their effectiveness. Bacterial viruses, bacteriophages (phages), are natural enemies of bacteria and use their lytic enzymes, endolysins (lysins), to specifically kill bacterial cells. Harnessing the potential of lysins to combat bacterial infections holds promise for diminishing antibiotic usage and, consequently, addressing the escalating antibiotic resistance in bacteria. In this context, we list the lysins with the activity against B. anthracis , providing a summary of their lytic properties in vitro and the outcomes observed in animal models. Bacillus cereus strain ATCC 4342/RSVF1, a surrogate for B. anthracis , was also included as a target bacteria. Key points • More than a dozen different B. anthracis lysins have been identified and studied. • They fall into three blocks regarding their amino acid sequence similarity and most of them are amidases. • Lysins could be used in treating B. anthracis infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Military Institute of Hygiene and Epidemiology, Biological Threats Identification and Countermeasure Center, Puławy, 24-100, Poland. aleksandra.nakonieczna@wihe.pl.
- Military Institute of Hygiene and Epidemiology, Biological Threats Identification and Countermeasure Center, Puławy, 24-100, Poland.
- National Veterinary Research Institute, Puławy, 24-100, Poland.
Zitieren
APA
Nakonieczna, A., Abramowicz, K., Kwiatek, M., & Kowalczyk, E. (2024). Lysins as a powerful alternative to combat Bacillus anthracis. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-024-13194-3
Vancouver
Nakonieczna A, Abramowicz K, Kwiatek M, Kowalczyk E. Lysins as a powerful alternative to combat Bacillus anthracis. Applied Microbiology and Biotechnology. 2024. doi:10.1007/s00253-024-13194-3
BibTeX
@article{Nakonieczna2024,
author = {Nakonieczna, Aleksandra and Abramowicz, Karolina and Kwiatek, Magdalena and Kowalczyk, Ewelina},
title = {Lysins as a powerful alternative to combat Bacillus anthracis},
journal = {Applied Microbiology and Biotechnology},
year = {2024},
doi = {10.1007/s00253-024-13194-3}
}
EUVIMED